Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 5, 1996, Pages 1110-1115

  Venge, Jonas ^a   Lampinen, Maria ^a   Håkansson, Lena ^a   Rak, Sabina ^a   Venge, Per ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

asthma; eosinophils; IL 5; lungs; RANTES

Indexed keywords

BETA1 INTEGRIN; CHEMOATTRACTANT; INTERLEUKIN 5; RANTES; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ARTICLE; ASTHMA; CELL ADHESION; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; COMPETITIVE INHIBITION; ENDOTHELIUM CELL; EOSINOPHIL; FEMALE; HUMAN; LUNG LAVAGE; MALE; POLLEN ALLERGY; PRIORITY JOURNAL;

EID: 0029992156     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70265-8     Document Type: Article

References (34)

1. Barnes PJ, Rodger IW, Thomson NC. Asthma. Basic mechanisms & clinical management. 2nd ed. London: Academic Press, 1992.
2. Dahl R, Venge P, Fredens K. The eosinophil. In: Barnes PJ, Rodger I, Thomson N, eds. Asthma: basic mechanisms and clinical management. London: Academic Press, 1992:111-24.
3. Nourshargh S. Mechanisms of neutrophil and eosinophil accumulation in vivo. Am Rev Respir Dis 1993;148(suppl):S60-S64.
4. Smith CH, Barker JNWN, Lee TH. Adhesion molecules in allergic inflammation. Am Rev Respir Dis 1993;148(suppl):S75-S78.
5. Venge P, Håkansson L. The eosinophil and asthma. In: Kaliner M, Barnes PJ, Persson CGA, eds. Asthma. Its pathology and treatment. New York: Marcel Dekker, 1991:477-502.
6. Alam R, Stafford S, Forsythe P, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993;150:3442-7.
7. Clark RA, Gallin JI, Kaplan AP. The selective eosinophil chemotactic activity of histamine. J Exp Med 1975;142:1462-76.
8. Sigal CE, Valonc FH, Holtzman MJ, Goctzl EJ. Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC). J Clin Immunol 1987;7:179-84.
9. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB. Interleukin-8 is a chemoattractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993;23:1027-36.
10. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994;55:183-91.
11. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-55.
12. Rak S, Håkansson L, Venge P. Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapy. Int Arch Allergy Immunol 1987;82:349-50.
13. Venge P, Dahl R, Håkansson L. Heat-labile neutrophil chemotactic activity in asthmatics after allergen inhalation challenge. Relation to the late asthmatic reaction and effects of asthma medication. J Allergy Clin Immunol 1987;80:679-88.
14. Venge P, Rak S, Håkansson L. Study of inflammatory mediators in asthma by bronchoalveolar lavage. In: Melillo G, Norman PS, Marone G, eds. Respiratory allergy. Toronto: B. C. Decker, 1990:105-10.
15. Venge P, Håkansson L. Indices of inflammatory activity in CB and COAD. Phagocyte secretion and chemotaxis. In: Persson CGA, Brattsand R, Laitincn LA, Venge P, eds. Inflammatory indices in chronic bronchitis. Basel: Birkhauser Verlag, 1990:219-28.
16. Rak S, Håkanson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol 1990;86:706-13.
17. Rak S, Bjoörnson A, Håkanson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-88.
18. Boner AL, Peroni DG, Piacentini GL, Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993;23:1021-6.
19. Håkansson L, Wcsterlund D, Venge P. A new method for the measurement of eosinophil migration. J Leukoc Biol 1987:42:689-96.
20. Håkansson L, Rak S, Dahl R, Venge P. The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. J Allergy Clin Immunol 1989;83:933-9.
21. Håkansson L, Venge P. The influence of serum on random migration and chemotaxis of polymorphonuclear leucocytes: methodological evaluation using sera from infection-prone patients and normals. Scand J Immunol 1980;11:271-82.
22. Zigmond SH, Hirsch JG. Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of cell-derived chemotactic factors. J Exp Med 1973;137:387-410.
23. Schmekel B, Venge P. Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response. Allergy 1993;48:94-7.
24. Yamaguchi Y, Hayashi Y, Sugama Y, et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-42.
25. Håkansson L, Venge P. Priming of eosinophil and neutrophil migratory responses by interleukin 3 and 5. APMIS 1994;102:308-16.
26. Dahinden CA, Geiser T, Brunner T, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994;179:751-6.
27. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
28. Baldwin ET, Franklin KA, Appella E. Crystallization of human interleukin-8. A protein chemotactic for neutrophils and T-lymphocytes. J Biol Chem 1990;265:6851-3.
29. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23.
30. Warringa RAJ, Mengelers HJJ, Raaijmakers JAM, Bruijnzeel PLB, Koenderman L. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993;91:1198-205.
31. Robinson DS, Durham SR, Kay AB. Cytokincs in asthma. Thorax 1993;48:845-53.
32. Desreumaux P, Janin A, Duhucquoi S, et al. Synthesis of interleukin-5 by activated eosinophils in patients with cosinophilic heart diseases. Blood 1993;82:1553-60.
33. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994;179:703-8.
34. Baggiolini M, Dahinden CA. CC chemokines in allergic inflammation. Immunol Today 1994;15:127-33.